Skip to content
lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
May 2, 2026
Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
May 2, 2026
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
May 1, 2026
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
May 1, 2026
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
April 30, 2026
Press release: Availability of the Q1 2026 aide-mémoire
April 30, 2026
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
April 29, 2026
Press Release: AAD: new results from Sanofi’s amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
March 30, 2026
Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
March 5, 2026
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
March 4, 2026
←
Previous Page
1
2
3
4
Next Page
→